Status:
COMPLETED
Comparing Self Monitored Blood Glucose (SMBG) to Continuous Glucose Monitoring (CGM) in Type 2 Diabetes
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
Roche Diagnostics GmbH
International Diabetes Center at Park Nicollet
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the use of SMBG and CGM for clinical decisions related to the management of type 2 diabetes. The secondary objective is to determine the benefit of using CGM f...
Detailed Description
This study involves the use of the following 2 glucose monitoring methods to measure your blood sugar (glucose) levels and help manage type 2 diabetes: 1. Self Monitoring Blood Glucose (SMBG): blood ...
Eligibility Criteria
Inclusion
- Male or female ≥18 and ≤75 years of age (Upper range to assure dexterity for use of CGM)
- Clinical diagnosis of type 2 diabetes
- HbA1c ≥7.0%
- Diabetes can be treated with any of the following therapies within one month prior to study enrollment: (1) medical nutrition therapy alone or with metformin; (2) sulfonylurea with or without metformin; (3) dipeptidyl peptidase 4 (DPP-4) inhibitor or Glucagon-like peptide-1 (GLP-1) agonist with or without metformin; or insulin with or without metformin.
Exclusion
- Treated with Thiazolidinediones (TZD)
- Administered prednisone or cortisone medications in the previous 30 days
- Currently pregnant or planning pregnancy during the study period
- Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise the subject's safety or successful participation in the study
- HbA1c \<7.0%
- Unable to follow the study protocol
- Unable to speak, read and write in English
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT01237301
Start Date
October 1 2010
End Date
March 1 2012
Last Update
October 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
International Diabetes Center
Minneapolis, Minnesota, United States, 55416